BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2005
View Archived Issues
Update on TGN-255 in the prevention of thrombosis
Read More
Add-on topiramate prevents body weight gain in schizophrenics treated with antipsychotics
Read More
Novel delivery of contortrostatin provides enhanced potential for clinical development
Read More
Halofuginone modulates T-cell functional activity
Read More
Cell death pathways investigated in TH-9402-mediated cytotoxicity
Read More
BMS-593214: a novel inhibitor of FVIIa
Read More
Natriuretic peptides may help predict outcome of patients with nonischemic CHF
Read More
Urocortin 2 shows promise in the treatment of congestive heart failure
Read More
Clinical data confirm the efficacy of solifenacin in overactive bladder
Read More
AL-208 set to enter phase I trials
Read More
Enrollment completed in U.S. phase I study of cetilistat for obesity
Read More
Agenix contracts Diosynth for manufacturing of ThromboView
Read More
BioSante licenses contraceptive technology from Wake Forest University
Read More
YM BioSciences licenses oncology compounds from U. of Saskatchewan
Read More
Phase II comparative study of R-112 for allergic rhinitis opens enrollment
Read More
AmpliMed licenses FB-642 and other compounds from UTR
Read More
CytoGenix forms research collaboration with Imperial College London
Read More
Encore awarded SBIR grant for work in neuroinflammation
Read More
Cenix delivers therapeutic targets to Bayer
Read More
Phase II trial begins for OGX-011 for NSCLC
Read More
Velcura and Nippon Chemiphar collaborate on osteoporosis drugs
Read More
NS-2330 results do not warrant phase III studies in Alzheimer's, Parkinson's
Read More
Pfizer submits Sutent NDA
Read More
Bioequivalence studies continue for fixed-dose Truvada/Sustiva product
Read More
Recent patents describe new antiinfective agents
Read More
New agents for treating obesity disclosed by Procter & Gamble
Read More
Novel therapeutics for fibroproliferative diseases reported by Scios
Read More